Mount Sinai's Cardiovascular Research Institute is sending bioengineered human heart muscle cells and micro-tissues into space for the first time on NASA's 29 th SpaceX commercial resupply services ...

Scientists from New York City-based Mount Sinai will send bioengineered human heart muscle cells and micro-tissues to space, according to a Nov. 14 news release shared with Becker’s. In doing so, ...

Johns Hopkins Medicine scientists who arranged for 48 human bioengineered heart tissue samples to spend 30 days at the International Space Station report evidence that the low gravity conditions in ...

Long-term space travel to Mars could be bad for astronauts' hearts, a new zero-gravity study shows. After a month at the International Space Station, a set of 48 bioengineered human heart tissue ...

The intricacies of excitable tissues, including cardiac, nervous, and skeletal muscle systems, pose substantial challenges in creating artificial analogs that can replicate their bioelectrical, ...

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

Bioengineered organs are no longer just structural substitutes. A review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) platforms—living ...